Nonmotor features of Parkinson's disease subtypes

Parkinson's disease is highly heterogeneous in early clinical features and later outcomes. This makes classifying subgroups of PD relevant to clinical research and practice, particularly if they are prognostically relevant. Subgroups have been defined both on the basis of motor and nonmotor features, and subgroups have been determined either empirically, based on clinical observation, or using data‐driven analytic techniques. Previous studies have examined both the overall number and the nature of nonmotor symptoms and signs in tremor‐dominant compared with non‐tremor‐dominant subtypes, and longitudinal studies identify nonmotor symptoms as important markers of prognosis and important defining features of PD subtypes. Autonomic features seem to preferentially affect individuals with non‐tremor‐dominant PD subtype early in the disease. Later in the disease cognitive disturbance distinguishes this phenotype. Pathological and neuroimaging studies provide substantial evidence for fundamental biological differences between tremor‐dominant and postural instability gait disorder/akinetic‐rigid subtypes. Biomarker studies point toward non‐tremor‐dominant PD as representing more advanced and diffuse neurodegeneration than tremor‐dominant PD, encompassing dopaminergic and nondopaminergic as well as synuclein and nonsynuclein (Abeta) pathologies. This aligns with clinical studies that find a higher burden of nonmotor symptoms in non‐tremor‐dominant PD. The mounting evidence for the relevance of nonmotor features in PD subtypes behooves us to begin to investigate the biological underpinnings of subtypes defined by both motor and nonmotor features. This may be challenging, as PD subtypes are unlikely to be distinct nonoverlapping entities but are more likely to represent typical phenotypes within a multidimensional spectrum resulting from variable contributions of a number of simultaneous pathological processes. © 2016 International Parkinson and Movement Disorder Society

[1]  H. Shill,et al.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.

[2]  K. Shannon,et al.  Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases , 2012, Movement disorders : official journal of the Movement Disorder Society.

[3]  C. Zhong,et al.  Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease , 2012, European Journal of Neurology.

[4]  W. Oyen,et al.  Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor , 2011, Annals of neurology.

[5]  K Ray Chaudhuri,et al.  Non‐motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non‐motor subtypes , 2015, European journal of neurology.

[6]  M. Vassallo,et al.  Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. , 2014, Neurodegenerative disease management.

[7]  Ajay S. Kurani,et al.  Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. , 2012, JAMA neurology.

[8]  C Adler,et al.  Olfactory function in Parkinson's disease subtypes , 1994, Neurology.

[9]  Marios Politis,et al.  Parkinson's disease symptoms: The patient's perspective , 2010, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. Speelman,et al.  Clinical heterogeneity in newly diagnosed Parkinson’s disease , 2008, Journal of Neurology.

[11]  E. Tolosa,et al.  Molecular and clinical prodrome of Parkinson disease: implications for treatment , 2010, Nature Reviews Neurology.

[12]  L. Defebvre,et al.  Cognitive and SPECT characteristics predict progression of Parkinson’s disease in newly diagnosed patients , 2004, Journal of Neurology.

[13]  A. Lang,et al.  Parkinson's disease subtypes: lost in translation? , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  Rachel J. Anderson,et al.  Depression and anxiety related subtypes in Parkinson's disease , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  D. Dickson,et al.  Neuropathology underlying clinical variability in patients with synucleinopathies , 2011, Acta Neuropathologica.

[16]  M. Stern,et al.  Milestones in Parkinson's disease—Clinical and pathologic features , 2011, Movement disorders : official journal of the Movement Disorder Society.

[17]  E. Tolosa,et al.  Multiple organ involvement by alpha‐synuclein pathology in Lewy body disorders , 2014, Movement disorders : official journal of the Movement Disorder Society.

[18]  R. Barker,et al.  The spectrum of nonmotor symptoms in early Parkinson disease , 2013, Neurology.

[19]  K. Jellinger Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts , 2012, Movement disorders : official journal of the Movement Disorder Society.

[20]  Schiess,et al.  Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. , 2000, Parkinsonism & related disorders.

[21]  D. Aarsland,et al.  The association between motor subtypes and psychopathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[22]  L. Defebvre,et al.  Apathy in untreated early‐stage Parkinson disease: Relationship with other non‐motor symptoms , 2014, Movement disorders : official journal of the Movement Disorder Society.

[23]  Giuseppe Orefice,et al.  The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients , 2013, PloS one.

[24]  M. Vidailhet [Heterogeneity of Parkinson's disease]. , 2003, Bulletin de l'Academie nationale de medecine.

[25]  U. Dillmann,et al.  Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[26]  O. Hornykiewicz,et al.  Globus pallidus dopamine and Parkinson motor subtypes , 2008, Neurology.

[27]  H. Sagar,et al.  A data‐driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes , 1999, Movement disorders : official journal of the Movement Disorder Society.

[28]  D. Aarsland,et al.  Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[29]  Nikolaus Weiskopf,et al.  Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease☆ , 2013, Parkinsonism & related disorders.

[30]  S. Landau,et al.  Parkinson's disease motor subtypes and mood , 2012, Movement disorders : official journal of the Movement Disorder Society.

[31]  A. Tröster,et al.  Parkinson's disease mild cognitive impairment: application and validation of the criteria. , 2014, Journal of Parkinson's disease.

[32]  Thomas Foltynie,et al.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.

[33]  Anette Schrag,et al.  Why do patients with Parkinson’s disease fall? A cross-sectional analysis of possible causes of falls , 2015, npj Parkinson's Disease.

[34]  Angelo Antonini,et al.  Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects , 2011, NeuroImage.

[35]  P. Kempster,et al.  Neuropathological findings in benign tremulous Parkinsonism , 2013, Movement disorders : official journal of the Movement Disorder Society.

[36]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[37]  T. Feng,et al.  Clinical heterogeneity in patients with early-stage Parkinson’s disease: a cluster analysis , 2011, Journal of Zhejiang University SCIENCE B.

[38]  L. Timmermann,et al.  Parkinson’s Disease Subtypes Show a Specific Link between Dopaminergic and Glucose Metabolism in the Striatum , 2014, PloS one.

[39]  David J. Brooks,et al.  A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need , 2013, PloS one.

[40]  T Revesz,et al.  A clinico-pathological study of subtypes in Parkinson's disease. , 2009, Brain : a journal of neurology.

[41]  T. Robbins,et al.  Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[42]  K. Kashihara,et al.  Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease. , 2010, Parkinsonism & related disorders.

[43]  S. Saiki,et al.  Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD , 2004, Journal of the Neurological Sciences.

[44]  J. Marinus,et al.  Relation of clinical subtypes in Parkinson's disease with survival , 2014, Movement disorders : official journal of the Movement Disorder Society.

[45]  O. Tysnes,et al.  Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild , 2011, Movement disorders : official journal of the Movement Disorder Society.

[46]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[47]  A. Espay,et al.  Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement , 2014, Movement disorders : official journal of the Movement Disorder Society.

[48]  H. Reichmann,et al.  Olfactory Function in Parkinson's Disease , 2010 .

[49]  Jeffrey M. Hausdorff,et al.  Cognitive function and other non-motor features in non-demented Parkinson’s disease motor subtypes , 2015, Journal of Neural Transmission.

[50]  G. Polesello,et al.  Clinical predictors in Parkinson's disease , 2002, Neurological Sciences.

[51]  Jean-François Gagnon,et al.  New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. , 2015, JAMA neurology.

[52]  Véronique Latreille,et al.  Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[53]  K. Chaudhuri,et al.  Non motor subtypes and Parkinson's disease. , 2016, Parkinsonism & related disorders.

[54]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.

[55]  E. Tolosa,et al.  When does Parkinson's disease begin? , 2009, Movement disorders : official journal of the Movement Disorder Society.

[56]  M. T. Pellecchia,et al.  Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[57]  W. Heiser,et al.  The identification of Parkinson's disease subtypes using cluster analysis: A systematic review , 2010, Movement disorders : official journal of the Movement Disorder Society.

[58]  K. Chaudhuri,et al.  The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review , 2015, npj Parkinson's Disease.

[59]  W. Koller,et al.  When does Parkinson's disease begin? , 1992, Neurology.

[60]  J. Trojanowski,et al.  CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease , 2010, Neurology.

[61]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[62]  Paolo Barone,et al.  International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[63]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[64]  J. Marinus,et al.  Motor patterns in Parkinson's disease: A data‐driven approach , 2009, Movement disorders : official journal of the Movement Disorder Society.

[65]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[66]  E. Tolosa,et al.  The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study) , 2015, Movement disorders : official journal of the Movement Disorder Society.

[67]  Turi O. Dalaker,et al.  Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.